In Tune

Occupancy fears hit shares in Southern Cross

The UK care homes operator may have far more empty beds than shareholders previously believed, as shares fall 14.5 per cent

AstraZeneca beats challenge to $4.4bn drug

US court has blocked cheaper versions of blockbuster schizophrenia treatment Seroquel from sale until 2011

Southern Cross drops further as forecasts cut

Share price of UK’s biggest care homes operator falls dramatically again as analysts cut forecasts by over half

Southern Cross fails to repay bank debt

Shares in Britain's biggest care homes operator plunge 58 per cent as it shows vulnerability to difficult credit markets

Tempus analysis: Not very well

Southern Cross has high operational gearing and its profits are weighted heavily towards the second half of the year

Rising death rate hits Southern Cross profit

The UK care home group issues profit warning and is given a month to pay £46m in debt after missing today's deadline

Fight against fat is a major industry

Pharmaceutical companies will cash in on diet treatments and medical devices in an industry that is worth $1.4 trillion

Botox salons inject beautiful profits

Cosmetic surgery clinic Sk:n plans to raise its number of treatment centres from 30 to 180 as makeover fever grips the nation

Virtual humans give real hope on drug costs

PricewaterhouseCoopers claims that drug costs could be reduced by up to $125m through computer-generated cells and organs

Guidelines could cut cost of medicines

Proposals to update the Pharmaceutical Price Regulation System include average price cuts of nearly 5 per cent

Ranbaxy and Pfizer agree Lipitor deal

An agreement on patents could add up to an extra $5 million for the US group from the bestselling cholestrol treatment

Pfizer agrees deal with Ranbaxy for Lipitor copy

Deal with Indian generics manufacturer gives drugs giant Pfizer an extra five months of sales, worth $5 billion

UK medicines bill to be cut in new price deal

Health department to consult on proposals to control branded drugs prices as new guidelines 'bring stability'

A cure for everything, including economic woe

Baba Ramdev's Indian yoga-based charity that preaches vegetarianism and ayurvedic medicine turns over £20 million a year

Ranbaxy rallies on Pfizer counterbid rumours

The world's biggest pharmaceuticals company may gatecrash Daiichi Sanko's bid to buy India's largest drug maker